Papassotiriou Ioannis, Stamoulakatou Alexandra, Wajcman Henri, Kister Jean, Dimisianos Gerasimos, Lazaropoulou Christina, Kanavaki Ino, Vavourakis Efstathios, Kattamis Antonios, Kanavakis Emmanuel, Traeger-Synodinos Joanne
Department of Clinical Biochemistry, Aghia Sophia Children's Hospital, Athens, Greece.
Hemoglobin. 2006;30(4):409-18. doi: 10.1080/03630260600867842.
We report clinical, hematological, biochemical, functional and molecular studies carried out on two first cousins from a Greek-Albanian family who have clinical and hematological findings consistent with the diagnosis of thalassemia intermedia. DNA studies determined that they had co-inherited a common Mediterranean beta-thalassemia (thal) mutation, IVS-I-110 (G-->A), in trans to a beta-globin gene mutation at codon 107 (GGC-->GAC), predicted to give rise to a rare unstable beta chain variant Hb Lulu Island or beta107(G9)Gly-->Asp.
我们报告了对来自一个希腊-阿尔巴尼亚家庭的两名堂兄弟进行的临床、血液学、生物化学、功能和分子研究。他们的临床和血液学检查结果与中间型地中海贫血的诊断相符。DNA研究确定,他们共同继承了一个常见的地中海β-地中海贫血(thal)突变,即IVS-I-110(G→A),该突变与密码子107处的β-珠蛋白基因突变(GGC→GAC)呈反式排列,预计会产生一种罕见的不稳定β链变体血红蛋白露露岛或β107(G9)甘氨酸→天冬氨酸。